Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANAB | RARE | ZYME | ||
| Company | Anaptysbio Inc | Ultragenyx Pharmaceu | Zymeworks Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 63.88 | 19.69 | 24.00 | ||
| High | 67.00 | 20.45 | 24.99 | ||
| Low | 63.24 | 19.61 | 23.97 | ||
| Latest | 64.99 | 20.00 | 24.69 | ||
| Change | -0.40 | +0.15 | +0.46 | ||
| % Change | -0.61% | +0.76% | +1.90% | ||
| Volume | 252,600 | 2,293,800 | 388,100 | ||
| 20-Day Average Volume | 602,400 | 2,164,950 | 781,015 | ||
| Previous Close | 65.39 | 19.85 | 24.23 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 61.55 | 21.32 | 24.05 | ||
| 20-Day Raw Stochastic | 78.36% | 33.11% | 42.33% | ||
| 20-Day Relative Strength | 61.92 | 40.85 | 54.19 | ||
| Weighted Alpha | +240.04 | -37.82 | +85.37 | ||
| Today's Opinion | 100% Buy | 100% Sell | 80% Buy | ||
| Previous Opinion | 100% Buy | 100% Sell | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.42% since 03/19/26 | -2.06% since 03/19/26 | +3.33% since 03/19/26 | ||
| Low | 60.92 on 03/24/26 | 18.29 on 03/24/26 | 23.23 on 03/24/26 | ||
| High | 67.00 on 03/26/26 | 20.68 on 03/20/26 | 24.99 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +15.83% since 02/26/26 | -13.19% since 02/26/26 | +3.70% since 02/26/26 | ||
| Low | 52.68 on 03/03/26 | 18.29 on 03/24/26 | 22.26 on 03/02/26 | ||
| High | 68.39 on 03/17/26 | 23.45 on 02/27/26 | 28.00 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +29.72% since 12/26/25 | -41.50% since 12/26/25 | -8.11% since 12/26/25 | ||
| Low | 42.00 on 01/06/26 | 18.29 on 03/24/26 | 21.93 on 02/23/26 | ||
| High | 68.39 on 03/17/26 | 25.82 on 02/03/26 | 28.00 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +175.61% since 09/26/25 | -31.22% since 09/26/25 | +48.73% since 09/26/25 | ||
| Low | 23.15 on 09/29/25 | 18.29 on 03/24/26 | 16.00 on 11/07/25 | ||
| High | 68.39 on 03/17/26 | 39.89 on 12/08/25 | 28.49 on 11/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,879,831 | 1,918,105 | 1,786,963 | ||
| Shares Outstanding, K | 28,748 | 96,630 | 73,750 | ||
| Annual Sales | 234,600,000 | 673,000,000 | 105,970,000 | ||
| Annual Net Income | -13,230,000 | -575,000,000 | -81,130,000 | ||
| Last Quarter Sales | 108,250,000 | 207,280,000 | 2,510,000 | ||
| Last Quarter Net Income | 49,610,000 | -128,560,000 | -41,210,000 | ||
| 60-Month Beta | 0.32 | 0.16 | 1.23 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.58 on 03/03/26 | -1.29 on 02/12/26 | -0.55 on 03/02/26 | ||
| Latest Earnings Date | 05/04/26 | 05/05/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||